ArticleFrontiers in pharmacology2025

Cost-effectiveness analysis of first-line treatments for recurrent or metastatic head and neck cancer in China: an economic evaluation based on network meta-analysis.

Fen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.